\ drug development Archives ~ ScienceBeta

ScienceBeta

Menu

Tag: drug development

Neurons That Suppress Fear Memories Hide In The Hippocampus

A group of cells in the brain that are responsible when a frightening memory re-emerges unexpectedly has been found by neuroscientists at the University of Texas at Austin. The discovery could lead to new recommendations about when and how often certain therapies are deployed for the treatment of anxiety, phobias and post-traumatic stress disorder (PTSD). […]

Serotonergic Circuitry Differs In SSRI Resistant Major Depressive Disorder Patients

Differences in growth patterns of neurons of SSRI-resistant patients have been discovered by researchers at Salk Institute. The work has implications for depression as well as other psychiatric conditions such as bipolar disorder and schizophrenia that likely also involve abnormalities of the serotonin system in the brain. Selective serotonin reuptake inhibitors (SSRIs) are the most […]

Beta Interferon Associated With Longer Survival For MS Patients

People with multiple sclerosis who took a beta interferon drug had a 32 per cent lower mortality risk than those that did not take the drug, a new study has found. The effect was particularly evident among MS patients who took beta interferon for more than three years. “This is a significant study. Although these […]

Schizophrenia: Adjunctive Antidepressant Treatment Reduced Risk Of Psychiatric Hospitalization

Certain combinations of psychiatric medication may be more effective than others in treating patients with schizophrenia, a new study suggests. Combining medications is often referred to as polypharmacy. Antipsychotic drugs are usually the first line of treatment for individuals with schizophrenia. But because these drugs often fail to control symptoms adequately on their own, doctors […]

Novel Ligands Reverse Memory Loss Linked To Aging

New therapeutic molecules show promise in reversing the memory loss linked to depression and aging. The ligands, developed at Toronto’s Centre for Addiction and Mental Health (CAMH), not only rapidly improve symptoms, but surprisingly, also appear to renew the underlying brain impairments causing memory loss in preclinical models. “Currently there are no medications to treat […]